Gene · 994
Papers2,079
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 2,079
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| FOXM1a Isoform of Oncogene FOXM1 Is a Tumor Suppressor Suppressed by hnRNP C in Oral Squamous Cell Carcinoma. | Biomolecules | 2023 | 37759731 | PubTator, text mining | PubMed |
| Withaferin A: A Dietary Supplement with Promising Potential as an Anti-Tumor Therapeutic for Cancer Treatment - Pharmacology and Mechanisms. | Drug Des Devel Ther | 2023 | 37753228 | PubTator, text mining | PubMed |
| Elucidation of E3 ubiquitin ligase specificity through proteome-wide internal degron mapping. | Mol Cell | 2023 | 37738965 | PubTator, text mining | PubMed |
| Beta-Transducin Repeats-Containing Proteins as an Anticancer Target. | Cancers (Basel) | 2023 | 37686524 | PubTator, text mining | PubMed |
| MC1R signaling through the cAMP-CREB/ATF-1 and ERK-NFκB pathways accelerates G1/S transition promoting breast cancer progression. | NPJ Precis Oncol | 2023 | 37679505 | PubTator, text mining | PubMed |
| An In Vitro Evaluation and Network Pharmacology Analysis of Prospective Anti-Prostate Cancer Activity from Perilla frutescens. | Plants (Basel) | 2023 | 37631218 | PubTator, text mining | PubMed |
| Increased Levels of miR-15b-5p and miR-20b-5p in Pancreatic Ductal Adenocarcinoma with Hepatic Metastases. | Genes (Basel) | 2023 | 37628628 | PubTator, text mining | PubMed |
| Role of Fork-Head Box Genes in Breast Cancer: From Drug Resistance to Therapeutic Targets. | Biomedicines | 2023 | 37626655 | PubTator, text mining | PubMed |
| A pan-cancer analysis of potassium channel tetramerization domain containing 12 in human cancer. | Sci Rep | 2023 | 37626178 | PubTator, text mining | PubMed |
| A New Mild Method for Synthesis of Marine Alkaloid Fascaplysin and Its Therapeutically Promising Derivatives. | Mar Drugs | 2023 | 37623705 | PubTator, text mining | PubMed |
| Chromosomal instability and a deregulated cell cycle are intrinsic features of high-risk gastrointestinal stromal tumours with a metastatic potential. | Mol Oncol | 2023 | 37622176 | PubTator, text mining | PubMed |
| Favorable outcomes of NPM1mut AML patients are due to transcriptional inactivation of FOXM1, presenting a new target to overcome chemoresistance. | Blood Cancer J | 2023 | 37607920 | PubTator, text mining | PubMed |
| The significance of ERK5 catalytic-independent functions in disease pathways. | Front Cell Dev Biol | 2023 | 37601096 | PubTator, text mining | PubMed |
| Development of an interfering peptide M1-20 with potent anti-cancer effects by targeting FOXM1. | Cell Death Dis | 2023 | 37598210 | PubTator, text mining | PubMed |
| Differential Modulation of the Phosphoproteome by the MAP Kinases Isoforms p38α and p38β. | Int J Mol Sci | 2023 | 37569817 | PubTator, text mining | PubMed |
| SNIP1 and PRC2 coordinate cell fates of neural progenitors during brain development. | Nat Commun | 2023 | 37553330 | PubTator, text mining | PubMed |
| Identification of genes critical for inducing ulcerative colitis and exploring their tumorigenic potential in human colorectal carcinoma. | PLoS One | 2023 | 37535606 | PubTator, text mining | PubMed |
| Natural Flavonoids Quercetin and Kaempferol Targeting G2/M Cell Cycle-Related Genes and Synergize with Smac Mimetic LCL-161 to Induce Necroptosis in Cholangiocarcinoma Cells. | Nutrients | 2023 | 37513508 | PubTator, text mining | PubMed |
| Interactions between circRNAs and miR-141 in Cancer: From Pathogenesis to Diagnosis and Therapy. | Int J Mol Sci | 2023 | 37511619 | PubTator, text mining | PubMed |
| Biomedical association analysis between G2/M checkpoint genes and susceptibility to HIV-1 infection and AIDS progression from a northern chinese MSM population. | AIDS Res Ther | 2023 | 37468905 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/994/papers?page=6